[go: up one dir, main page]

WO2010062034A3 - Liquid eye drop or gel type pharmaceutical composition containing vitis vinifera seed extract - Google Patents

Liquid eye drop or gel type pharmaceutical composition containing vitis vinifera seed extract Download PDF

Info

Publication number
WO2010062034A3
WO2010062034A3 PCT/KR2009/005750 KR2009005750W WO2010062034A3 WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3 KR 2009005750 W KR2009005750 W KR 2009005750W WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
eye drop
seed extract
gel type
vitis vinifera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/005750
Other languages
French (fr)
Korean (ko)
Other versions
WO2010062034A2 (en
Inventor
박세완
이근혁
류종현
김재신
박진하
곽은영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanlim Pharmaceutical Co Ltd
Original Assignee
Hanlim Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanlim Pharmaceutical Co Ltd filed Critical Hanlim Pharmaceutical Co Ltd
Publication of WO2010062034A2 publication Critical patent/WO2010062034A2/en
Publication of WO2010062034A3 publication Critical patent/WO2010062034A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a liquid eye drop or gel type pharmaceutical composition which contains vitis vinifera seed extract; and an antioxidant selected from a group consisting of ascorbic acid or a salt thereof, sodium hydrogen sulfite, potassium pyrosulfite, and L-threonine or a salt thereof. The pharmaceutical composition according to the present invention maintains a physical and chemical stability over a long period of time. Therefore, the pharmaceutical composition of the present invention can be stored over a long period of time, and valuably used in the field of drug manufacture.
PCT/KR2009/005750 2008-11-28 2009-10-08 Liquid eye drop or gel type pharmaceutical composition containing vitis vinifera seed extract Ceased WO2010062034A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080119366A KR101047356B1 (en) 2008-11-28 2008-11-28 Pharmaceutical compositions in the form of eye drops or gels containing seed extracts of European grapes
KR10-2008-0119366 2008-11-28

Publications (2)

Publication Number Publication Date
WO2010062034A2 WO2010062034A2 (en) 2010-06-03
WO2010062034A3 true WO2010062034A3 (en) 2010-08-19

Family

ID=42226198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005750 Ceased WO2010062034A2 (en) 2008-11-28 2009-10-08 Liquid eye drop or gel type pharmaceutical composition containing vitis vinifera seed extract

Country Status (2)

Country Link
KR (1) KR101047356B1 (en)
WO (1) WO2010062034A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (en) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 Oral Pharmaceutical Compositions Containing Anthocyanosides
WO2003086442A2 (en) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
WO2007127844A2 (en) * 2006-04-28 2007-11-08 Alcon, Inc. Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
WO2008007244A2 (en) * 2006-06-08 2008-01-17 The Iams Company Composition for improving eye health

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (en) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 Oral Pharmaceutical Compositions Containing Anthocyanosides
WO2003086442A2 (en) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
WO2007127844A2 (en) * 2006-04-28 2007-11-08 Alcon, Inc. Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
WO2008007244A2 (en) * 2006-06-08 2008-01-17 The Iams Company Composition for improving eye health

Also Published As

Publication number Publication date
WO2010062034A2 (en) 2010-06-03
KR101047356B1 (en) 2011-07-07
KR20100060673A (en) 2010-06-07

Similar Documents

Publication Publication Date Title
BR112014009031A2 (en) metal ion stabilized etanercept formulations
WO2012153193A3 (en) Protein-active agent conjugates and method for preparing the same
MX2009011165A (en) Pharmaceutical formulations containing lipoic acid derivatives.
EA201170958A1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODYPINE AND LOZARTAN AND METHOD FOR ITS PREPARATION
EP2486793A3 (en) Stable S-(+)-abscisic acid liquid and soluble granule formulations
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
TW200833351A (en) New cosmetic and/or pharmaceutical compositions and their applications
MY157582A (en) Medical composition containing rebamipipe
EA201201239A1 (en) A composition comprising as active ingredients L-CARNITINE IN COMBINATION WITH hydroxykynurenine-O-BETA-DL-glucoside FOR PREVENTING AND / OR TREATING PATHOLOGIES eyes caused by ultraviolet radiation
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
MX2009007265A (en) Salts, aqueous liquid compositions containing salts of s-(+)-abscisic acid and methods of their preparation.
WO2010025859A3 (en) Stabilization of cells by ionic liquids
NO20091990L (en) Substituted pyrazoles, compositions containing them, methods of preparation and use
DE602007014206D1 (en) Novel serotonin reuptake inhibitor as a drug with peripheric system-restricted activity
WO2010056527A3 (en) B-biphenyl sulfonamide compounds as ion channel modulators
GEP20135859B (en) Stable combined pharmaceutical composition
WO2009129208A8 (en) Compositions and methods of inducing endoplasmic reticulum stress reponse
WO2012033390A3 (en) Novel thiophene derivative as sglt2 inhibitor and pharmaceutical composition comprising same
IN2015DN02596A (en)
EA201001353A1 (en) GIDROBROMID IUBRADINA
BRPI0700133A (en) pharmaceutical composition comprising tramadol and ketoprofen in combination
WO2010062034A3 (en) Liquid eye drop or gel type pharmaceutical composition containing vitis vinifera seed extract
EA201300882A1 (en) METHOD OF TREATMENT CONSTIPATION AND / OR SEALING OF FECAL MASSES, AQUEOUS SOLUTION FOR TREATING CONSTIPATION AND / OR SEALING OF FECAL MASSES (OPTIONS), KIT AND MEDICATION
WO2011041609A3 (en) Topical formulations
WO2009120844A3 (en) Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2